HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Srushti Kittane Selected Research

Chromatin

5/2024Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer.
10/2020FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Srushti Kittane Research Topics

Disease

5Neoplasms (Cancer)
05/2024 - 10/2020
3Breast Neoplasms (Breast Cancer)
05/2024 - 10/2020

Drug/Important Bio-Agent (IBA)

2AlpelisibIBA
05/2024 - 01/2022
2Estrogen ReceptorsIBA
05/2024 - 10/2020
2ChromatinIBA
05/2024 - 10/2020
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
05/2024
1Hormones (Hormone)IBA
05/2024
1selpercatinibIBA
01/2022
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2022
1Protein Isoforms (Isoforms)IBA
01/2022
1Phosphotransferases (Kinase)IBA
01/2021
1Aromatase InhibitorsIBA
10/2020
1Transcription Factors (Transcription Factor)IBA
10/2020

Therapy/Procedure

2Therapeutics
05/2024 - 01/2022